Investment Stage

Focus Areas

About Investor

Nathalie Weitemeyer is Director Life Science and Senior Investment Manager at Bayern Kapital, a regional venture capital firm in Bavaria. She backs startups in biotech, health IT, health & hospital services, material science and SMB software, typically from seed through Series B, with investment tickets in the $100K to $5.0M range. A chemist by training, she has been financing life science and medtech startups at Bayern Kapital since 2001. She also completed a postgraduate business administration degree and has guided multiple portfolio companies through clinical development phases.